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Similarities in innate immune signaling exist between mammals and the nematode Caenorhabditis elegans.
Now, Ziegler et al. (2009) and Ren et al. (2009) demonstrate that a protein kinase C d homolog in C. elegans is
involved in innate immunity, providing evidence that the conservation of immune signaling networks extends
further than previously thought.Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc. 313Similarities exist in mammalian and
invertebrate immune signaling, and
common virulence factors are involved
in both vertebrate and invertebrate path-
ogenesis (Mylonakis and Aballay, 2005).
Invertebrates rely solely on an innate
immune system to protect themselves
from pathogens, and studies on the
innate immune system of invertebrates
have provided a promising start to
understanding the complexity of this
system in vertebrates. In particular, the
ability to use Caenorhabditis elegans in
high-throughput assays and in several
advanced molecular studies has gener-
ated significant interest on the use of this
model system for investigation of innate
immunity.
The discovery of a conserved p38 MAP
kinase cascade was pivotal to our under-
standing of C. elegans immunity (Kim
et al., 2002). This was followed by studies
that describe a number of other pathways
that function in innate immunity in the
nematode. We now know that, in addition
to the p38 MAP kinase cascade, an ERK
MAP kinase pathway, a DAF-2/DAF-16
insulin-like signaling pathway, and
a TGF-b pathway are important compo-
nents of the nematode immune signaling
network. However, little is known about
how the nematode senses the presence
of a pathogen and the subsequent relay
process culminating in p38/PMK-1 kinase
activation.In the mammalian immune signaling
network, the novel isoform protein kinase
C theta (PKCq) is an integral member, link-
ing T cell receptor stimulation with nuclear
factor-kB (NF-kB) activation in lympho-
cytes. Studies have also demonstrated
that the novel PKC isoform PKCd is
involved in immune response signaling.
In the macrophage, PKCd directly binds
to the adaptor protein TIRAP/Mal, which
is responsible for relaying signals sensed
by two Toll-like receptors (TLRs), TLR-2
and TLR-4, ultimately resulting in activa-
tion of IKK, a kinase responsible for degra-
dation of IkB conferring NF-kB activation
(Kubo-Murai et al., 2007). Other studies
have demonstrated NF-kB-dependent
gene expression increases due to direct
phosphorylation of IkB, either by PKCd or
by a downstream effector such as protein
kinase D (PKD) (Steinberg, 2004). In addi-
tion, PKCd is also involved in regulation of
NF-kB, independently of IKK/IkB, by
acting on the p38 MAP kinase, and PKCd
and the MAP kinase p38 are also involved
in apoptotic signaling in some tissues
(Steinberg, 2004).
Now, two independent studies have
identified the C. elegans PKCd, TPA-1,
as a key component acting before the
p38 kinase cascade-mediated immune
response (Figure 1) (Ren et al., 2009; Zie-
gler et al., 2009). Using the nematode
fungal pathogen Drechmeria coniospora,
Ziegler et al. (2009) identified severalcomponents contributing to the p38/
PMK-1 MAP kinase-mediated immune
response by monitoring the expression
of the antimicrobial peptide NLP-29.
Several components functioning before
activation of TPA-1 were also identified
including two phospholipase C proteins
(EGL-8 and PLC-3) and the a and
b subunits of a G protein complex. Inter-
estingly, a second PKC (PKC-3) was
also involved in nlp-29 expression in
a nonredundant manner with TPA-1, and
the placement of PKC-3 in the immune
signaling network suggests it is also
upstream of the TIP domain adaptor
protein, TIR-1, as this protein is important
for nlp-29 expression (Couillault et al.,
2004). In an intestinal pathogen-C.
elegans model, Pseudomonas aeruginosa
was used to identify components acting
upstream of the kinase cascade (Ren
et al., 2009). The PKD DKF-2 was found
to be involved in p38/PMK-1-mediated
immune response to pathogens. DKF-2
is activated by phosphorylation via TPA-1.
This PKD is essentially inactive when
C. elegans consumes nonpathogenic
bacteria, has weak activity when mildly
pathogenic bacteria are consumed, and
has the highest amount of catalytic
activity when highly pathogenic bacteria
are ingested. Thus, the intensity of intes-
tinal DKF-2 activity not only represents
the level of TPA-1 activity, but also
acts as an endogenous biosensor
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Pathway
An unknown GPCR responds to the presence of a pathogen activating the G protein complex, which then
activates phospholipase C proteins, stimulating the synthesis of the messenger signal DAG (purple phos-
pholipids), which then activates TPA-1 and eventually the p38/PMK MAP kinase cascade. This composite
figure summarizes data regarding signaling in different tissues, and it should be noted that a number of
components are absent in some tissues; e.g., DKF-2 and TOL-1 are not required in the epidermis. Solid
arrows represent hypothesized direct interactions between the proteins, whereas dashed arrows indicate
a suspected pathway that may contain other unknown proteins. The families of proteins are color coded as
follows: G protein subunits, purple; phospholipase C, orange; protein kinase C, dark green; protein kinase
D, olive green; Tribbles-like kinase, light blue; TIR domain adaptor protein, light yellow; the p38/PMK-1
MAP kinase cascade, blue; other proteins involved in innate immunity, gray. GPCR, G protein-coupled
receptor.corresponding to the degree of virulence
of the pathogenic microbe. Signals trans-
mitted by activated DKF-2 intersect with
the p38/PMK-1 pathway and trigger
phosphorylation and activation of PMK-
1. Ren et al. (2009) find that DKF-2 also
promotes immunity by a PMK-1-indepen-
dent mechanism that remains to be eluci-
dated. The immediate downstream target
of DKF-2 is currently unknown, but kinase
activation elicits an increase in >75
mRNAs encoding immune effectors.
Taken together, the PLC enzymes
appear to activate TPA-1 through the
messenger compound diacylglycerol
(DAG), which in turn activates other
signaling components in the p38
pathway. Of note is that there appears to
be a divergence in this pathway, depend-
ing on the tissue involved in the infection
process. In intestinal cells, DKF-2 is acti-
vated by DAG synthesis via TPA-1 (Ren
et al., 2009); however, in epithelial cells,314 Cell Host & Microbe 5, April 23, 2009 ª2there appears to be no activation or
involvement of any of the PKD proteins
in C. elegans (Ziegler et al., 2009), all of
which is supported by the observation
that DKF-2 is expressed primarily in the
intestine (Ren et al., 2009).
Ziegler et al. (2009) did not identify
any corresponding G protein-coupled
receptors (GPCRs), which act upon the G
protein signaling complex partially
composed of GPA-12 (the a subunit)
and/or RACK-1 (the b subunit). However,
two previously identified GPCRs,
FSHR-1 and NPR-1, are known to
be involved in the C. elegans immune
response. FSHR-1 is an important
component of innate immunity in the intes-
tine, but the data suggests that it either
functions in a parallel immune pathway
or is one of at least two receptors involved
in the p38-mediated immune response
and must also function in an alternative
immune pathway (Powell et al., 2009).009 Elsevier Inc.The hypothesis of multiple receptors
and/or G protein signaling complexes is
supported by the fact that gpa-12mutants
retain a significant level of nlp-29 expres-
sion when compared to nematodes
harboring a mutation in the p38 homolog,
pmk-1 (Ziegler et al., 2009). As the Trib-
bles-like kinase NIPI-3 functions in the
p38-mediated immune response by
activating TPA-1 independently of the
G protein GPA-12, it is a good candidate
for being a component in an alternative
pathway that converges at TPA-1
upstream of the MAP kinase cascade (Zie-
gler et al., 2009). The second GPCR,
NPR-1, has been postulated to be involved
in the p38-mediated immune response
(Styer et al., 2008), although another study
has suggested NPR-1 is involved in
sensing and ‘‘avoidance’’ of the nematode
from the pathogen (Reddy et al., 2009).
Although the C. elegans TLR, TOL-1,
may be involved in the immune response
in an intestinal model of Salmonella enter-
ica infection, it is not involved in the regula-
tion of nlp-29 expression in the epidermis
(Couillault et al., 2004). Recently, homo-
logs of CD36 and SCARF-1, two mamma-
lian scavenger receptors, have been
identified in C. elegans as CED-1 and
C03F11.1, respectively. They are involved
in expression of antimicrobial peptides by
recognizing b-glucan in the cell wall of
fungal pathogens (Means et al., 2009).
Whether either of these receptors is
involved in eventual activation of the p38/
PMK-1 kinase cascade (or a parallel
immune response pathway) remains to
be determined.
In summary, understanding the immune
responses of C. elegans expands our
understanding of highly preserved innate
immunity traits. Different C. elegans
receptor(s) are involved in recognizing
pathogens, and the conservation of the
p38 MAP kinase cascade among evolu-
tionarily diverse organisms demonstrates
its importance in innate immunity.
However, the signaling pathway ultimately
leading to activation of this cascade has
numerous variables. Importantly, the
proteins involved in the signaling for this
cascade are dependent on the C. elegans
tissue type that is sensing and responding
to the pathogen (Ren et al., 2009; Ziegler
et al., 2009), and analysis of expression
patterns of immune response genes indi-
cates that there is a pathogen-specific
profile of transcripts (Wong et al., 2007).
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response gene expression could be due
to various receptors activating the p38/
PMK-1 MAP kinase cascade in addition
to parallel alternative immune pathways.
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response. In humans, they are believed to
regulate 30% of all cellular genes (for
a review, see Bartel, 2004).
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between viruses and their hosts, including
immune control of virus infection. So far,
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Barr virus (EBV), and Kaposi’s sarcoma-
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Since miRNAs can be efficiently tar-
geted with chemically modified antisense
oligonucleotides, so-called antagomirs
(Krutzfeldt et al., 2005), viral miRNAs
present themselves as interesting candi-
dates for novel antiviral drugs. However,
in order to develop antiviral drugs based
on viral miRNAs, a detailed understanding
of their targets and function is required.
Since only a few bases of a miRNA define
its target specificity, identification of
miRNA targets by computational means
is often difficult. For cellular miRNAs,
such bioinformatic algorithms rely heavily
on evolutionary conservation of both
miRNAs and their targets. Since viral
miRNAs show no or very minimal
sequence conservation, only very few
targets of herpesvirus miRNAs have so
be 5, April 23, 2009 ª2009 Elsevier Inc. 315
